The role of herpes simplex thymidine kinase gene transfer in the drug treatment of brain tumours

CNS Drugs

Volumn 6, Issue 1, 1996, Pages 1-11

  Culver, Kenneth W ^a  

^a Oncor Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

BRAIN TUMOR; GENE TRANSFER; HERPES SIMPLEX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; VIRUS GENE;

EID: 0029957749     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199606010-00001     Document Type: Review

References (63)

1. Blaese RM, Culver KW, Anderson WF. The ADA human gene therapy clinical protocol. Hum Gene Ther 1990; 1: 331-62
2. Osborne WRA, Hock RA, Kaleko M, et al. Long-term expression of human adenosine deaminase in mice after transplantation of bone marrow infected with amphotropic retroviral vectors. Hum Gene Ther 1990; 1: 31-41
3. Blaese RM, Culver KW, Miller AD, et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995; 270: 475-80
4. Culver KW. Gene therapy: a handbook for physicians. New York: MA Liebert, 1996
5. Culver KW, Blaese RM. Gene therapy for cancer. Trends Genet 1994; 10: 174-8
6. Elion GB. The chemotherapeutic exploitation of virus-specified enzymes. Adv Enz Regulation 1980; 18: 53-66
7. Colbere-Garapin F, Chousterman S, Horodniceanu F, et al. Cloning of the active thymidine kinase gene of herpes simplex virus type 1 in Escherichia coli K-12. Proc Natl Acad Sci USA 1979; 76: 3755-9
8. Faulds D, Heel RC. Ganciclovir: a review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs 1990; 39: 597-38
9. Terry BJ, Cianci CW, Hagen ME. Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1a,2b,3a)]-9-[2,3-Bis(hydroxymethyl)cyclobutyl]guanine. Mol Pharm 1991; 40: 591-6
10. Smee DF, Martin JC, Verheyden JPH, et al. Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine. Antimicrob Agents Chemother 1983; 23: 676-82
11. Samejima Y, Meruelo D. 'Bystander killing' induces apoptosis and is inhibited by forskolin: plasmid pXtk construction for thymidine-kinase gene transfer to investigate bystander killing. Gene Ther 1995; 2: 50-8
12. Field AK, Davies ME, DeWitt C, et al. 9-([2-hydroxy-1-(hyroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. Proc Natl Acad Sci USA 1983; 80: 4139-43
13. Gutierrez AA, Lemoine NR, Sikora K. Gene therapy for cancer. Lancet 1992; 339: 715-21
14. Moolten FL. Tumor sensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a perspective cancer control strategy. Cancer Res 1986; 46: 5276-81
15. Ezzedine ZD, Martuza RL, Platika D, et al. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol 1991; 3: 608-14
16. Moolten FL, Wells JM, Heyman RA, et al. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum Gene Ther 1990; 1: 125-34
17. Smee DF, Boehme R, Chernow M, et al. Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells. Biochem Pharmacol 1985; 34: 1049-56
18. Cheng Y-C, Grill SP, Dutschman GE, et al. Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes-simplex virus-infected cells. J Biol Chem 1983; 258: 12460-4
19. Shepp DH, Dandliker PS, de Miranda P, et al. Activity of 9-[2-hydroxy-1-(hydroxy-methyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia. Ann Int Med 1985; 103: 368-73
20. Stankus BJ. Cytovene product monograph. Palo Alto: Syntex Laboratories Inc., 1992
21. Salmons B, Gunzburg WH. Targeting of retroviral vectors for gene therapy. Hum Gene Ther 1993; 4: 129-41
22. Donahue RE, Kessler SW, Bodine D, et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992; 176: 1125-35
23. Ram Z, Culver KW, Walbridge S, et al. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993; 53: 83-8
24. Yamada M, Shimizu K, Miayo Y, et al. Retrovirus-mediated gene transfer targeted to malignant glioma cells in murine brain. Jpn J Cancer Res 1992; 83: 1244-7
25. Short MP, Choi JK, Lee A, et al. Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J Neuroscience Res 1990; 27: 427-33
26. Culver KW, Ram Z, Walbridge S, et al. In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-2
27. Barba D, Hardin J, Ray J, et al. Thymidine kinase-mediated killing of rat brain tumors. J Neurosurg 1993; 79: 729-35
28. Brody SL, Jaffe HA, Han SK, et al. Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors: cancer therapy strategy. Hum Gene Ther 1994; 5: 437-47
29. Akli S, Caillaud C, Vigne E, et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet 1993; 3: 224-8
30. Bajocchi G, Feldman SH, Crystal RG, et al. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet 1993; 3: 229-34
31. Davidson BL, Allen ED, Kozarsky KF, et al. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet 1993; 3: 219-23
32. La Salle GL, Robert JJ, Berrard S, et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 1993; 259: 988-90
33. Smythe WR, Hwang HC, Amin KM, et al. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res 1994; 54: 2055-9
34. Bonnekoh B, Greenhalgh DA, Bundham DS, et al. Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer in vivo. J Invest Dermatol 1995; 104: 313-7
35. Vile RG, Hart IR. In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res 1993; 53: 962-7
36. Byrnes AP, Rusby JE, Wood MJA, et al. Adenovirus gene transfer causes inflammation in the brain. Neuroscience 1995; 66: 1015-24
37. Coen DM, Kosz-Vnenchak M, Jacobson JG, et al. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci USA 1989; 86: 4736-40
38. Boviatsis EJ, Park JS, Sena-Esteves M, et al. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res 1994; 54: 5745-51
39. Martuza RL, Malick A, Markert JM, et al. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 1991; 252: 854-6
40. Ulmer JB, Donnelly JJ, Parker SE, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1745-9
41. Tang D, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356: 152-4
42. Nabel J, Chang A, Nabel EG, et al. Immunotherapy of malignancy by in vivo gene transfer into tumors. Hum Gene Ther 1992; 3: 399-410
43. Zhu N, Liggitt D, Liu Y, et al. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993; 261: 209-11
44. Yoshida J, Mizuno M, Yagi K. Cytotoxicity of human -interferon produced in human glioma cells transfected with its gene by means of liposomes. Biochem Intl 1992; 28: 1055-61
45. Wu GY, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 1987; 262: 4429-32
46. Wagner E, Zenke M, Cotten M, et al. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA 1990; 87: 3410-4
47. Jiao S, Cheng L, Wolff JA, et al. Particle bombardment-mediated gene transfer and expression in rat brain tissues. Biotechnology 1993; 11: 497-502
48. Bi WL, Parysek LM, Warnick R, et al. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 1993; 4: 725-31
49. Fick J, Barker FGII, Dazin P, et al. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc Natl Acad Sci USA 1995; 92: 11071-5
50. Elshami AA, Saavedra A, Zhang H, et al. Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther 1996; 3: 85-92
51. Hooper ML, Subak-Sharpe JH. Metabolic cooperation between cells. Int Rev Cytol 1991; 69: 45-104
52. Plautz G, Nabel EG, Nabel GJ. Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol 1991; 7: 709-15
53. Chen S-H, Shine HD, Goodman JC, et al. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 1994; 91: 3054-7
54. Freeman SM, Abbou CN, Whartenby KA, et al. The 'bystander effect': tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-83
55. Ram Z, Walbridge S, Shawker T, et al. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Neurosurg 1994; 81: 256-60
56. Wu JK, Cano WG, Meylaerts SAG, et al. Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery 1994; 35: 1094-103
57. Culver KW, Moorman DW, Muldoon RR, et al. Toxicity and immunologic effects of in vivo retrovirus-mediated gene transfer of the herpes simplex-thymidine kinase gene into solid tumors. Cold Spring Harb Symp on Quant Biol 1994; 59: 683-90
58. Weisacker M, Deen DF, Rosenblum ML, et al. The 9L rat brain tumor model: description and application of the model. J Neurol 1981; 224: 183-92
59. Ram Z, Culver KW, Walbridge S, et al. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J Neurosurg 1993; 79: 400-7
60. Oldfield EH, Ram Z, Culver KW, et al. A clinical protocol: gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993; 4: 39-69
61. Culver KW, Van Gilder J, Link Jr CJ, et al. Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ ganciclovir system. Hum Gene Ther 1993; 5: 343-77
62. Raffel C, Culver KW, Kohn D, et al. Gene therapy for the treatment of recurrent pediatric malignant astrocytomas using in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther 1994; 5: 863-90
63. Oldfield EH, Ram Z, Chiang Y, et al. Intrathecal gene therapy for the treatment of leptomeningeal carcinomatosis: a phase I/II study. Hum Gene Ther 1995; 6: 55-85